Target Therapy for Hepatocellular Carcinoma: Beyond Receptor Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and its incidence is steadily increasing. The development of HCC is a complex, multi-step process that is accompanied by alterations in multiple signaling cascades. Recent years have seen advancement in un...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hyunjung, Park, Hyerin, Baek, Jiyeon, Moon, Hyuk, Ro, Simon Weonsang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027240/
https://www.ncbi.nlm.nih.gov/pubmed/35453784
http://dx.doi.org/10.3390/biology11040585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027240/
https://www.ncbi.nlm.nih.gov/pubmed/35453784
http://dx.doi.org/10.3390/biology11040585

Ejemplares similares